136055-64-6

Basic information

• Product Name: No
• Synonyms: (E)-2-(3-Hydroxy-4-methoxyphenyl)ethyl 4-[3-(4-hydroxy-3-methoxyphenyl)-2-propenoate] beta-D-glucopyranoside;Desrhamnosylmartynoside;b-D-Glucopyranoside, 2-(3-hydroxy-4-methoxyphenyl)ethyl, 4-[3-(4-hydroxy-3-methoxyphenyl)-2-propenoate], (E)-
• CAS NO: 136055-64-6
• Molecular Formula: C25H30O11
• Molecular Weight: 506.4991
• Mol File: 136055-64-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: No(CAS DataBase Reference)
• NIST Chemistry Reference: No(136055-64-6)
• EPA Substance Registry System: No(136055-64-6)

Safety Data

• Hazardous Substances Data: 136055-64-6(Hazardous Substances Data)

Usage

General Description

Desrhamnosylmartynoside is a type of chemical compound classified as a flavonoid glycoside. It is found in various plant sources, particularly in the Flacourtiaceae family. Desrhamnosylmartynoside possesses antioxidant properties and is believed to have potential therapeutic effects, including anti-inflammatory and anti-cancer properties. It also has been researched for its potential application in the treatment of various ailments, including cardiovascular diseases. However, further studies are necessary to fully understand its mechanisms of action and potential health benefits.

Related news

Full Length ArticleNew insight into simultaneous removal of No (cas 136055-64-6) and Hg0 on CeO2-modified V2O5/TiO2 catalyst: A new modification strategy09/03/2019

In this work, it was theoretically speculated that enhancing NO adsorption will simultaneously improve SCR performance and Hg0 oxidation on a V-based SCR catalyst. As a result, CeO2 was selected as the modification component. The results indicated that CeO2 modification not only significantly im...detailed

Full Length ArticleFormation and reduction of No (cas 136055-64-6) from the oxidation of NH3/CH4 with high concentration of H2O09/02/2019

This study investigated the homogeneous formation and reduction of NO from the oxidation of CH4/NH3 to understand the effect of the high concentrations of H2O on NO emissions. The experimental results about the effects of excess oxygen ratio, gas compositions including H2O, CO2, NH3 and recycled...detailed

The synergistic effect of fluorination and embedded SNo (cas 136055-64-6)2 on the No (cas 136055-64-6) gas sensing of expanded graphite09/01/2019

To achieve high-performance nitric oxide (NO) gas sensing, expanded graphite (EG) was modified with SnO2 and fluorine functional groups. SnO2 was introduced into EG with an aqueous solution of SnCl2, whereas the fluorine functional groups were introduced via fluorine gas. The properties of the s...detailed

Ergosterols from GaNo (cas 136055-64-6)derma sinense and their anti-inflammatory activities by inhibiting No (cas 136055-64-6) production08/31/2019

Three new ergosterols, ganocalidophins A–C (1‒3), along with four known ones, were isolated from the fruiting bodies of Ganoderma sinense. Their structures were established on the basis of extensive NMR and MS technologies, as well as the single crystal X-ray diffraction. Compounds 1‒3 and 6 ex...detailed

Theoretical investigation of oxidation of No (cas 136055-64-6) (No (cas 136055-64-6) + ½ O2 → No (cas 136055-64-6)2) on surfaces of nickel-doped naNo (cas 136055-64-6)cages (Ni–C60 and Ni–B30N30)08/30/2019

In present study, the NO oxidation on Ni-carbon nanocage and Ni-boron nitride nanocage surfaces was investigated. The Ni–C60 and Ni–B30N30 catalysts can oxidize the NO molecule by Langmuir-Hinshelwood (LH) and Eley-Rideal (ER) mechanisms. In this study, the NO molecule was joined to Ni atom of...detailed

HematologíaLinfomas No (cas 136055-64-6) Hodgkin: actitud terapéutica08/29/2019

Los linfomas malignos se dividen en dos grupos: los linfomas de Hodgkin (10% de los linfomas) y los linfomas no Hodgkin (LNH). Los LNH consisten en una proliferación tumoral de células procedentes de las estirpes linfoides B o T. Pueden aparecer a cualquier edad de la vida, pero son más frecu...detailed

Parental opinions towards the “No (cas 136055-64-6) Jab, No (cas 136055-64-6) Pay” policy in Australia08/28/2019

BackgroundIn 2016, Australia introduced the “No Jab, No Pay” legislation, which removed the option of non-medical exemptions from the vaccination requirements to receive certain family and child care tax benefits. We aimed to gauge parental support for “No Jab, No Pay” and explore how it has...detailed